<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Encasement on Gromet's Plaza Archive</title><link>/tags/encasement/</link><description>Recent content in Encasement on Gromet's Plaza Archive</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Tue, 14 Nov 2006 00:00:00 +0000</lastBuildDate><atom:link href="/tags/encasement/index.xml" rel="self" type="application/rss+xml"/><item><title>The Epidemic</title><link>/stories/2006/11/14/the-epidemic/</link><pubDate>Tue, 14 Nov 2006 00:00:00 +0000</pubDate><guid>/stories/2006/11/14/the-epidemic/</guid><description>&lt;p&gt;The author wishes to thank B3=s Wendy, Latex Elf, Lanky in Latex, and others from Rubber Pal for their
generous help with ideas and inspiration.&lt;/p&gt;
&lt;p&gt;The epidemic was
raging, striking one community after another. While it seemed to affect
only a minority of the people, those who did catch the disease had more than
a 30% mortality rate. Since its first appearance a couple of years earlier,
the scientific and medical communities had been struggling to find
treatments or vaccines. There had been only limited success until a few
months ago when a lab in the UK had discovered how to make a vaccine based
on antibodies taken from survivors who had caught the disease and recovered
from it. The main problem was that the antibody concentration in blood and
other body fluids was too low to produce commercial quantities of vaccine.&lt;/p&gt;</description></item></channel></rss>